source
- FDA’s top gene-therapy regulator Vijay Kumar steps down amid leadership shake-upVijay Kumar, the acting director of the FDA office that reviews cell and gene therapies, has announced he will leave his position. In an email to staff, Kumar said he reflected on his tenure and de…
- AstraZeneca to Pay $34 Million Settlement Over Texas Medicaid Kickback AllegationsAstraZeneca has agreed to a $34 million settlement with the Texas attorney general over allegations that it provided improper incentives to boost prescriptions covered by Texas Medicaid. The state…